Spotlight on RAMQ coverage for FreeStyle Libre

Continuous glucose monitoring (CGM) systems offer lots of benefits, including reducing—or even eliminating—finger pricks and making it easier to prevent hypoglycemia and hyperglycemia episodes. The technology has proven to be a revolution for many, but its high cost remains a significant drawback.     Abbott’s own CGM system, the FreeStyle Libre, is covered under the … Read moreSpotlight on RAMQ coverage for FreeStyle Libre

Highlights and New Studies on Hypoglycemia in Type 1 Diabetes from the 2019 EASD Annual Meeting

Each year, the European Association for the Study of Diabetes (EASD) presents the results of the latest diabetes research at its Annual Meeting. The last such event was held from September 16 to 20, 2019. Here are some of the hypoglycemia-related highlights: – Severe hypoglycemia (episodes that result in a loss of consciousness or need another … Read moreHighlights and New Studies on Hypoglycemia in Type 1 Diabetes from the 2019 EASD Annual Meeting

Diabetes Canada 2019 – There is no easy way to predict blood sugar fluctuations following a meal

Achieving optimal blood sugar control after a meal is a great challenge that often seems to be a random turn of events one can rarely predict. This represents a reality that those living with type 1 diabetes are very familiar with. Here are the key messages from Lorraine Anderson’s, RD, CDE  presentation on this topic … Read moreDiabetes Canada 2019 – There is no easy way to predict blood sugar fluctuations following a meal

Fiasp® insulin approved for insulin pumps in the United States

As of October 22nd, 2019, Novonordisk’s ultra-fast insulin Fiasp® is now approved for insulin pumps in the United States. This insulin analogue, already approved in Quebec for people who inject insulin with a pen or syringe, is a fast-acting insulin that is even faster than the usual rapid insulins (Novorapid®, Apidra®, Humalog®). The faster mode … Read moreFiasp® insulin approved for insulin pumps in the United States

Diabetes Canada 2019 – Adolescence: How Development Influences Involvement in Type 1 Diabetes Treatment

Type 1 diabetes is often diagnosed in childhood. In most cases, parents are directly responsible for their child’s medical care until the latter becomes progressively more independent in their teen years. But how can we ensure a smooth transition from paediatric care to adult care so that young people can become self-sufficient in their treatment? Dr. Jennifer … Read moreDiabetes Canada 2019 – Adolescence: How Development Influences Involvement in Type 1 Diabetes Treatment

An Interview with Anne Jarry : Digital Tools Are Revolutionizing the Treatment of Diabetes

Anne Jarry is a professor at Université de Montréal’s School of Optometry. She lost her sight at the age of 24 and has been living with type 1 diabetes since she was nine years old. Part of her work involves testing new technologies to make them accessible to people with visual disabilities. Today, she’ll be telling us about … Read moreAn Interview with Anne Jarry : Digital Tools Are Revolutionizing the Treatment of Diabetes

New recommendations for continuous glucose monitoring systems and time in range

Continuous glucose monitoring (CGM) systems give more information than capillary blood sugar meters. This information is displayed directly on the reader, allowing the user to quickly take proper action and anticipate low blood sugar episodes, and is also used in reports to help better analyze blood sugar trends over a certain period, for example two … Read moreNew recommendations for continuous glucose monitoring systems and time in range

Can cannabis use be linked to a risk of diabetic ketoacidosis?

Cannabis, also known as marijuana, is now legalized in Canada, but its effects in relation to diabetes remain poorly known. Previous studies have found links between cannabis use and improved insulin sensitivity in people living with type 2 diabetes. Which means that cannabis use may increase the body’s ability to metabolize sugar in the blood … Read moreCan cannabis use be linked to a risk of diabetic ketoacidosis?

UK builds consensus for better access to new technologies

To help people living with diabetes manage their blood sugar levels, more and more technologies, such as new insulin pumps or new continuous glucose monitors, are available. These devices offer new possibilities such as : Continuous blood glucose meters that communicate with certain watches or smartphones to easily and discreetly check blood sugar levels. Moreover, … Read moreUK builds consensus for better access to new technologies